Samantha McLemore Patient Capital Management
Samantha McLemore is the founder of Patient Capital Management and previously worked closely with Bill Miller on value-oriented strategies. Her firm emphasizes long-term, research-driven equity investing with a willingness to hold unconventional or out-of-favor ideas. McLemore’s portfolio is followed by investors who track the next generation of independent value managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norwegian Cruise Line
NCLH
|
+$12.2M |
| 2 |
Alibaba
BABA
|
+$11.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$10.6M |
| 4 |
DXC Technology
DXC
|
+$10.5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$10.4M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.03% |
| 2 | Technology | 12.27% |
| 3 | Communication Services | 7.84% |
| 4 | Financials | 7.75% |
| 5 | Healthcare | 7.71% |
Similar funds
Samantha McLemore's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Samantha McLemore, which disclosed 43 positions worth $347M. Its ten largest holdings account for 47% of the portfolio.
Its largest position is Norwegian Cruise Line: 508,800 shares worth $10.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, followed by Technology and Communication Services.
- Samantha McLemore's largest Q4 2021 buy was Norwegian Cruise Line: 508,800 shares worth $10.6M.
- Samantha McLemore's ten largest holdings make up 47% of its $347M portfolio in Q4 2021.
- Samantha McLemore disclosed 43 positions in Q4 2021, its first 13F filing on record.
Based on Patient Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.